ACCESS BIO

CareStart™ COVID-19 IgM/IgG

Rapid test for antibodies to the SARS-CoV-2 Virus

The CareStart™ COVID-19 IgM/IgG is a CE-approved, lateral flow immuno-chromatographic assay for the detection of SARS-CoV-2 IgM/IgG antibodies in human blood specimens. This test differentiates IgM and IgG specific to SARS-CoV-2 in a single test within 10 minutes. CareStartTM COVID-19 IgM/IgG is manufactured by Access-bio Inc, an industry leading diagnostics business.

Manufactured Entirely in the U.S. by a U.S. Headquartered Company

Detect and differentiate IgM/IgG antibody specific to SARS-CoV-2

Fast and easy to use in CLIA certified laboratories

Requires a small sample volume (10 uL of whole blood, serum, or plasma)

No special equipment or training required. Results in 10 minutes.

Overall clinical performance: 100% sensitivity and 97.5% specificity

The CareStart™ COVID-19 IgM/IgG is a CE-approved, lateral flow immuno-chromatographic assay for the detection of SARS-CoV-2 IgM/IgG antibodies in human blood specimens. This test differentiates IgM and IgG specific to SARS-CoV-2 in a single test within 10 minutes. CareStartTM COVID-19 IgM/IgG is manufactured by Access-bio Inc, an industry leading diagnostics business.

Manufactured Entirely in the U.S. by a U.S. Headquartered Company

Detect and differentiate IgM/IgG antibody specific to SARS-CoV-2

Fast and easy to use in CLIA certified laboratories

Requires a small sample volume (10 uL of whole blood, serum, or plasma)

No special equipment or training required. Results in 10 minutes.

2021 Santa Monica Blvd, #11
Santa Monica, CA 90404

info@carestart.com


    2021 Santa Monica Blvd, #11
    Santa Monica, CA 90404

    info@carestart.com